CIK 0001869105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BridgeBio Oncology Therapeutics, Inc.
Sign in to watch- Ticker
- BBOT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857 702 0377
- Business address
- 256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Helix Acquisition Corp. II
- 4 Shares withheld for taxes Principal Accounting Officer gave up 203 shares (to pay taxes)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 126 shares (to pay taxes)
- 4 Shares withheld for taxes COO & Principal Financial Ofcr gave up 343 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,047 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Med & Dev Officer gave up 1,047 shares (to pay taxes)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 203 shares (to pay taxes)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 125 shares (to pay taxes)
- 4 Shares withheld for taxes COO & Principal Financial Ofcr gave up 343 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Med & Dev Officer gave up 1,047 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,047 shares (to pay taxes)
- 4 Other disposition Director disposed of 4,528,186 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 4 · 69 filings